Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gavin Cloherty

Showing results (91-100 of 127) with videos related to

Pageof 13
Sort By:
IJID Regions|May 26, 2023
Detection of SARS-CoV-2 antibodies after confirmed Omicron BA.1 and presumed BA.4/5 infections using Abbott ARCHITECT and Panbio assaysMichael Boler, Mark Anderson, Mary Rodgers, et al.
Hepatology Communications|September 24, 2021
Analysis of HBsAg Immunocomplexes and cccDNA Activity During and Persisting After NAP-Based TherapyMichel Bazinet, Mark Anderson, Victor Pântea, et al.
Hepatology (Baltimore, Md.)|June 30, 2022
HBV transcription and translation persist despite viral suppression in HBV-HIV co-infected patients on antiretroviral therapyMauricio Lisker-Melman, Abdus S Wahed, Marc G Ghany, et al.
Gut|August 8, 2020
Role of serum HBV RNA and hepatitis B surface antigen levels in identifying Asian patients with chronic hepatitis B suitable for entecavir cessationWai-Kay Seto, Kevin Sh Liu, Lung-Yi Mak, et al.
Hepatology Communications|April 3, 2022
HBsAg isoform dynamics during NAP-based therapy of HBeAg-negative chronic HBV and HBV/HDV infectionMichel Bazinet, Mark Anderson, Victor Pântea, et al.
Journal of Hepatology|April 18, 2016
Clinical value of on-treatment HCV RNA levels during different sofosbuvir-based antiviral regimensBenjamin Maasoumy, Johannes Vermehren, Martin-Walter Welker, et al.
AIDS (London, England)|February 15, 2022
Hepatitis B surface antigen and hepatitis B RNA changes in HIV/hepatitis B virus co-infected participants receiving hepatitis B virus-active antiretroviral therapyClaudia Hawkins, Minhee Kang, Debika Bhattacharya, et al.
American Journal of Epidemiology|April 21, 2023
A Mixture Model for Estimating SARS-CoV-2 Seroprevalence in Chennai, IndiaMatt D T Hitchings, Eshan U Patel, Rifa Khan, et al.
The Lancet. Global Health|August 20, 2021
Arresting vertical transmission of hepatitis B virus (AVERT-HBV) in pregnant women and their neonates in the Democratic Republic of the Congo: a feasibility studyPeyton Thompson, Camille E Morgan, Patrick Ngimbi, et al.
The Journal of Clinical Investigation|February 3, 2025
Transcription of hepatitis B surface antigen shifts from cccDNA to integrated HBV DNA during treatmentMaraake Taddese, Tanner Grudda, Giulia Belluccini, et al.
Pageof 13

Showing results (91-100 of 127) with videos related to

Sort By:
Pageof 13
IJID Regions|May 26, 2023
Detection of SARS-CoV-2 antibodies after confirmed Omicron BA.1 and presumed BA.4/5 infections using Abbott ARCHITECT and Panbio assaysMichael Boler, Mark Anderson, Mary Rodgers, et al.
Hepatology Communications|September 24, 2021
Analysis of HBsAg Immunocomplexes and cccDNA Activity During and Persisting After NAP-Based TherapyMichel Bazinet, Mark Anderson, Victor Pântea, et al.
Hepatology (Baltimore, Md.)|June 30, 2022
HBV transcription and translation persist despite viral suppression in HBV-HIV co-infected patients on antiretroviral therapyMauricio Lisker-Melman, Abdus S Wahed, Marc G Ghany, et al.
Gut|August 8, 2020
Role of serum HBV RNA and hepatitis B surface antigen levels in identifying Asian patients with chronic hepatitis B suitable for entecavir cessationWai-Kay Seto, Kevin Sh Liu, Lung-Yi Mak, et al.
Hepatology Communications|April 3, 2022
HBsAg isoform dynamics during NAP-based therapy of HBeAg-negative chronic HBV and HBV/HDV infectionMichel Bazinet, Mark Anderson, Victor Pântea, et al.
Journal of Hepatology|April 18, 2016
Clinical value of on-treatment HCV RNA levels during different sofosbuvir-based antiviral regimensBenjamin Maasoumy, Johannes Vermehren, Martin-Walter Welker, et al.
AIDS (London, England)|February 15, 2022
Hepatitis B surface antigen and hepatitis B RNA changes in HIV/hepatitis B virus co-infected participants receiving hepatitis B virus-active antiretroviral therapyClaudia Hawkins, Minhee Kang, Debika Bhattacharya, et al.
American Journal of Epidemiology|April 21, 2023
A Mixture Model for Estimating SARS-CoV-2 Seroprevalence in Chennai, IndiaMatt D T Hitchings, Eshan U Patel, Rifa Khan, et al.
The Lancet. Global Health|August 20, 2021
Arresting vertical transmission of hepatitis B virus (AVERT-HBV) in pregnant women and their neonates in the Democratic Republic of the Congo: a feasibility studyPeyton Thompson, Camille E Morgan, Patrick Ngimbi, et al.
The Journal of Clinical Investigation|February 3, 2025
Transcription of hepatitis B surface antigen shifts from cccDNA to integrated HBV DNA during treatmentMaraake Taddese, Tanner Grudda, Giulia Belluccini, et al.
Pageof 13